FDA Investigator CDR Donald Ertel
CDR Donald Ertel has inspections in 6 countries as of 01 Sep 2023. CDR Donald Ertel has collaborated with a combinined 2820 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
France,
Mexico,
United States of America,
Ireland,
Denmark,
Germany
Co-Investigator(s):
Alexey Khrenov, PhD,
Alicia M Mozzachio,
Amy Hsu, PhD,
Andrew "Drew" Haack, PhD,
Andrew Haack, PhD,
Andrew K Haack, PhD,
Anita Narula, PhD,
Anita R Michael,
Ann Marie Montemurro,
Ann Marie Schofield,
Arie C Menachem,
Azza Talaat,
Barbara Janine Breithaupt,
Barbara M Frazier,
Bijoy Panicker,
Bradley Dworak, PhD,
Brentley S Collins,
Brian Janelsins, PhD,
Bruce D Meade,
Burnell M Henry,
CDR Cecily Jones,
Charles Yuanchia Kuo, PhD,
Chava Kimchi Sarfaty, PhD,
Christian D Lynch (CDL),
Christine A Harman, PhD,
Christopher R Czajka,
Craig D Zagata,
Cynthia Jim, CSO,
Cynthia L Kelley,
Daniel C Kearns,
David E Bailey,
Deborah M Trout,
Destry M Sillivan,
Devaughn Edwards,
Dino Feigelstock (DF), PhD,
Dr. Gang Wang, PhD,
Dr. Willie F Vann, PhD,
Edmund F Mrak, Jr,
Edmund Fmrakjr S,
Eliezar Ramos,
Gene D Arcy,
Graeme E Price,
Graeme Price,
Helen B Ricalde,
Holly Brevig,
J David Doleski,
Jacqueline Mdiaz Albertini,
Jakob Reiser, PhD,
James E Keller, PhD,
James M Mason,
James R Evans,
Jean Lhu Primmer,
Jennifer L Bridgewater,
Jennifer L Schmidt,
Jeremy W Rotton,
Joan A Loreng,
Joan Johnson,
John F Cipollo,
John M Mcinnis,
Jose E Melendez, DDC,
Joseph George,
Julie D Bringger,
Justin A Boyd,
Kathryn E King,
Kelly R Lewis,
Kevin P Foley,
Kristy A Zielny,
Kula N Jha,
Laura Fontan, MS,
Laurel A Beer,
Lauren M Lilly, PhD,
Laurie P Norwood,
LCDR Debra Emerson,
Linda Thai,
Lisa K Capron,
Lisa P Oakes,
Lisa Pierce Oakes,
Lori P Peters,
Lori Peters,
Lydia S Chan,
Madushini Dharmasena, PhD,
Marion Michaelis,
Mariza M Jafary,
Marsha W Major,
Meisha R Sampson,
Meisha Waters,
Michael C Kennedy, PhD,
Michael Havert, PhD,
Michael S Araneta,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele L Obert,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Mra Davism,
Myra K Casey,
Nancy T Waites,
Nataniel Phillips Sylvain, PhD,
Nicole K Trudel,
Nikisha M Bolden,
Omotunde O Osunsanmi,
Patrick C Klotzbuecher,
Patsy J Domingo,
Paula A Trost,
Phillip C Thai,
Prabhu P Raju,
Rabia Ballica, PhD,
Ralph A Erickson,
Ramon E Martinez,
Rebecca K Olin,
Reyes Candau Chacon, PhD,
Richard Heath Coats,
Richard Ledwidge (nmi), PhD,
Richard W Thornton,
Riley C Myers, PhD,
Riley Meyers,
Robert C Coleman,
Robert Sausville,
Robert W Fisher,
Robert W Jennings,
Rose M Ashley,
S Lori Brown, PhD MPH,
Sarah B Tanksley,
Scott E Norris,
Scott T Ballard,
Sean R Bryd,
Sharon K Thoma, PharmD,
Sidney B Priesmeyer,
Simone E Pitts,
Solomon Yimam (SY),
Steven B Hertz,
Steven C Derrick,
Steven E Bowen, PhD,
Steven Fong, MS, PhD,
Susan F Laska, MS,
Susan M Jackson,
Teegan Dellibovi Ragheb, PhD,
Tina S Roecklein,
Unnee Ranjan,
V Teres Speer,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Wayne E Seifert,
Wei Wanet,
Wei Wang, PhD,
William D Tingley,
Yideng Liang,
Yonggang Wang, PhD,
Yuan Chia Kuo,
Yumi J Hiramine,
Zhenzhen Liu, PhD,
Zhong Li, PhD,
Zhongren Wu
CDR Donald Ertel's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2017 | FDA 483 Response | KITE PHARMA, INC. - Form 483R, 2017-06-29 |
| June, 2011 | FDA 483 | Instituto Bioclon S.A. de C.V. - Form 483, 2011-06-22 |
| June, 2017 | EIR | KITE PHARMA, INC. - EIR, 2017-06-16 |
| June, 2017 | FDA 483 | SAFC Carlsbad Inc. - Form 483, 2017-06-22 |
| October, 2015 | EIR | AGC Biologics A/S - EIR, 2015-10-13 |
| April, 2016 | FDA 483 | AGC Biologics, Inc. - Form 483, 2016-04-22 |
| June, 2017 | FDA 483 | KITE PHARMA, INC. - Form 483, 2017-06-16 |
| August, 2018 | FDA 483 | Laboratorios Silanes, S.A. de C.V. - Form 483, 2018-08-03 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more